Introduction
============

Muscle-biased therapies belong to the National Center for Complementary and Alternative Medicine category of manipulative and body-based practices. Muscle-biased therapy (MBT) includes a variety of interventions that manipulate the soft tissues of the body, through manual (eg, hands-on) or instrument-assisted techniques, and by applying fixed or movable pressure to the skin, muscles, and connective tissues. A considerable amount of variation exists in the way MBT treatments are provided in clinical practice and across research studies. Treatment variation includes the manner in which soft tissues are manipulated, the pressure intensity perceived by the patient (eg, light, deep, painful yet tolerable), the duration of sustained pressure, the duration of a single session of MBT, and the dosage of MBT (number of sessions). Nonetheless, MBT interventions are currently used by a number of health care professionals and have a long history as a therapeutic modality.[@b1-jpr-6-007]

In the US, MBT is widely used to manage pain associated with a variety of muscular and nonmuscular pain conditions,[@b2-jpr-6-007]--[@b6-jpr-6-007] and its popularity is growing. From 2002 to 2007, visits to health care professionals providing MBT increased, despite an overall decrease in the number of visits to complementary and alternative medicine practitioners during the same time period.[@b2-jpr-6-007],[@b5-jpr-6-007] In 2007, back pain was the most common problem for which adults sought MBT care, and roughly 60% of those adults experienced a "great deal" of benefit in reducing pain intensity following manipulative and body-based treatment, including MBT.[@b2-jpr-6-007],[@b4-jpr-6-007] However, a number of systematic reviews have reported similar themes of inconsistent, inconclusive, and insufficient evidence for the clinical effectiveness of MBT. These reviews focused on the effect of MBT on various pain-related conditions, including musculoskeletal pain,[@b7-jpr-6-007],[@b8-jpr-6-007] headache,[@b9-jpr-6-007] neck pain,[@b10-jpr-6-007] shoulder disorders,[@b11-jpr-6-007] low back pain,[@b12-jpr-6-007]--[@b14-jpr-6-007] cancer-related pain,[@b15-jpr-6-007] and exercise-induced pain (ie, delayed-onset muscle soreness).[@b16-jpr-6-007] A universal recommendation from those reviews for future MBT research has been to articulate the optimal therapeutic technique and dosing regimen.[@b7-jpr-6-007]--[@b9-jpr-6-007],[@b12-jpr-6-007]--[@b18-jpr-6-007] Currently, there are no clear definitions of what constitutes an adequate MBT treatment in terms of intensity or duration.[@b9-jpr-6-007],[@b17-jpr-6-007],[@b18-jpr-6-007]

We suggest that treatment parameters for MBT may be established through the use of intermediate physiologic endpoints. Studies that examine other modalities, such as transcutaneous electrical nerve stimulation, have addressed the lack of evidence for optimal intervention parameters through such means. For example, the optimal stimulation intensity for transcutaneous electrical nerve stimulation was identified using pain sensitivity as an intermediate physiologic outcome. The transcutaneous electrical nerve stimulation intensity of "strong but comfortable" was shown to produce the optimal analgesic effects compared with other intensities.[@b19-jpr-6-007]--[@b22-jpr-6-007] We suggest using a similar approach to develop optimal parameters of MBT. Based on current models of the mechanisms underlying therapeutic benefit, intermediate biologic and psychologic endpoints might include measures of physical and mental relaxation, changes in pain sensitivity, changes in local blood perfusion, changes in local biochemical milieu, and shifts in the autonomic nervous system.[@b12-jpr-6-007],[@b13-jpr-6-007]

Changes in pain sensitivity have been measured in several MBT randomized controlled trials and are recommended as objective outcomes.[@b9-jpr-6-007],[@b23-jpr-6-007],[@b24-jpr-6-007] Further, a recent systematic review and meta-analysis of a joint-biased therapy found a small but favorable increase in pressure pain thresholds following a single session of spinal manipulation when compared with all other therapies combined.[@b25-jpr-6-007] However, the authors did not examine whether the favorable changes in pain sensitivity were related to a clinical endpoint. Muscle-biased and joint-biased therapies, although distinguished by their targeted tissues, belong to the same National Center for Complementary and Alternative Medicine category of manipulative and body-based practices and are suggested to share similar neurophysiologic mechanisms underlying pain relief.[@b26-jpr-6-007] However, there are no systematic reviews summarizing the effect of MBT on pain sensitivity and whether these effects are related to clinical pain or are influenced by treatment parameters.

Thus, the purpose of this review was to summarize and critically evaluate the current literature investigating the short-term effect of a single dose of MBT in randomized controlled trials on pain sensitivity in both pain-free and clinical pain populations. We aimed to address three primary questions within this review, ie, whether MBT affects pain sensitivity, whether MBT intensity and/or duration influences pain sensitivity, and whether there are short-term changes in pain sensitivity associated with changes in clinical pain over similar time points. To address the first question, we used meta-analysis to estimate the pooled effect of MBT across trials within a pain sensitivity measure. We planned two a priori subgroup analyses. The first subgroup analysis examined the effect of MBT on pain sensitivity compared with interventions stratified by type (ie, no intervention, sham intervention, or active intervention). The second subgroup analysis stratified responses following MBT by population (ie, clinical or healthy). The results of these analyses will establish whether MBT has an overall effect on pain sensitivity and whether these differ based on population or comparison group.

To address the second question, we categorized MBT interventions based on intensity (eg, whether pain was induced during an MBT session or not) and duration (eg, based on application time) and examined the associations between these two variables and pain sensitivity changes. These results will implicate the importance of these parameters on pain sensitivity. Finally, to address the third question, we explored the congruence between short-term changes in pain sensitivity and changes in clinical pain over similar time points within studies involving clinical samples. These results will provide an indirect indication of whether pain sensitivity changes are clinically meaningful. Our results will also potentially provide preliminary evidence to direct future research addressing the gap in our understanding of optimal duration and intensity of MBT.

Materials and methods
=====================

A similar methodologic approach was used as our previously published systematic review and meta-analysis, which was conducted in accordance with the guidelines from Preferred Reporting Items for Systematic review and Meta-Analysis (PRISMA).[@b25-jpr-6-007],[@b27-jpr-6-007]

Eligibility criteria
--------------------

Study eligibility was based on study design, population, MBT intervention, comparison group, and outcome. We included randomized controlled trials that investigated the effects of a single session of MBT on pain sensitivity. Randomized controlled trials could be either multigroup (between-subject) or single-group (within-subject) crossover trials. We excluded descriptive and nonexperimental observational studies such as case series.

The sample populations of interest were human adults (\>18 years of age) with or without a clinical pain condition. We did not limit the sample to participants with a specific musculoskeletal pain condition, because MBT is applied to relieve pain in patients with a variety of clinical conditions.

We included studies that listed MBT as the primary intervention. We adopted the classification system of manipulative and body-based practices reported by Bialosky et al.[@b26-jpr-6-007] The MBT interventions included in this review were those directed at the muscle and soft tissues of the body. Examples of MBT included Swedish, Thai, Shiatsu, and deep tissue massage (stroking and kneading of the skin and underlying soft tissue using various amount rhythmic of pressure), myofascial release (applying sustained pressure to elongate soft and connective tissue), trigger point therapy (deep pressure to areas of local tenderness), and cross-friction massage (deep pressure applied transversely to specific tissues).[@b26-jpr-6-007] Excluded therapies included joint-biased (eg, joint mobilization and manipulation) and nerve-biased (eg, passive, combined movements of the spine and extremities, within their normal range of motion, in ways to elongate or tension specific nerves) techniques.[@b26-jpr-6-007] The intervention may have been applied to a single region (ie, back or lower extremity) or to multiple regions (ie, full body). Studies with cointerventions were included if the cointerventions were part of the comparison treatment to allow for the difference in treatment effect to be attributed to the addition of MBT in the experimental group. Studies that included multiple sessions of MBT were included if the short-term changes in pain sensitivity could be discerned following the first treatment session.

The comparison group included any form of active or nonactive interventions or no treatment controls. Examples of active interventions were physical modalities and other forms of manual therapy. Nonactive interventions included inert or sham interventions. No treatment control groups included those receiving advice, home instructions, or quiet rest, without any other intervention.

The primary outcome of interest was a change in a pain sensitivity measure. Studies needed to employ a between-group or within-subject repeated-measures design with the measurements taken before and after the intervention. Specific characteristics of the pain sensitivity measure of interest included the experimental sensory modality used, the psychophysical response, and the location of the stimulus application. The experimental sensory modality could have included chemical, electrical, ischemic, mechanical, and thermal stimuli. The psychophysical response could have been either static (ie, threshold, tolerance, or suprathreshold rating) or dynamic (ie, change in perception to repeated stimuli) measures. The location of the experimental stimulus application was considered in relation to the region where MBT was applied. If the location was in the same anatomical region receiving the MBT, it was considered local. If the location was outside the anatomical region receiving the MBT, it was considered remote.

Data sources
------------

Relevant articles were identified by performing a comprehensive search for studies in MEDLINE (PubMed) and Cumulative Index to Nursing and Allied Health Literature (CINAHL) from the inception of each database until July 2012. Search terms included: musculoskeletal manipulations \[MESH; major topic\], "manual therapy", "massage", "alternative therapies", "myofascial release", "myofascial therapy", "trigger point therapy", pain \[MESH; major topic\], "pain measurement" \[MESH; major topic\], "quantitative sensory testing", "thermal pain", "electrical pain", "pressure pain", "mechanical pain", "pain threshold", "muscle pain", "experimental pain", and "trigger point". The search strategy for both databases is listed in [Table 1](#t1-jpr-6-007){ref-type="table"}. MEDLINE limits were: "abstracts", "humans", "clinical trial", "randomized controlled trial", and "English language." CINAHL limits were: "abstract available", "English language", "peer reviewed", "research article", "human", and "all adult". Database searches were conducted on August 1, 2012. The search strategy used for both databases is listed in [Table 1](#t1-jpr-6-007){ref-type="table"}. In addition, manual searches through reference lists of relevant articles and previously published systematic reviews were performed to identify additional articles.

Study search and selection
--------------------------

All articles were screened for eligibility into this review by the primary author (CWG). A manual search of reference lists was conducted by all members of the research team to identify additional studies. A systematic screening procedure was used to identify relevant articles. First, article titles were reviewed within each database search list. Second, abstracts were screened if the title did not yield adequate information for study inclusion. Based on title and abstract, articles were deemed as potentially relevant and further screened, while all other were excluded. Finally, two authors (MJA and CWG) independently reviewed the full texts of all potentially relevant articles for final inclusion in the review. Any disagreements regarding article inclusion were resolved by consensus. If a consensus could not be reached, a third author (MEH) was recruited to resolve disagreement.

Data extraction
---------------

Two authors (MJA and CWG) independently extracted data from each of the included articles using a standardized Microsoft Excel 2007 (Microsoft Corporation, Redmond, WA) template. Results of each author's extraction were compared to ensure accuracy of the data. Each article was reviewed for key information: type of randomized trial; participant characteristics, including total number of subjects, number of subjects within each group, gender, and clinical condition; type of intervention within groups, including cointerventions; duration of treatment; perceived intensity of treatment (eg, painful or nonpainful); pain sensitivity outcome and region in which stimulus was applied; and results of the study (pre-post mean values and standard deviation for each measure within each group). The primary author of the respective article was contacted if any of the above information was unobtainable. If a response was not provided within 14 days of being contacted, the information was not included in the review. Two authors were contacted for additional information[@b28-jpr-6-007],[@b29-jpr-6-007] and one provided a response.[@b29-jpr-6-007]

Methodologic quality assessment
-------------------------------

Risk of potential bias was assessed by using the recommendations provided by the "Cochrane Handbook for Systematic Reviews of Interventions".[@b30-jpr-6-007] Each article was assessed for potential bias in five domains: selection bias, performance bias, attrition bias, reporting bias, and detection bias.[@b30-jpr-6-007] A 12-item scale was used to assess the internal validity of each study. Articles were then individually categorized as: low risk of bias (plausible bias unlikely to alter the results seriously) if there was low risk of bias for all key domains; unclear risk of bias (plausible bias that raises some doubt about the results) if unclear risk of bias for one or more key domains; or high risk of bias (plausible bias that seriously weakens confidence in the results) if high risk of bias for one or more key domains.[@b30-jpr-6-007] Prior to assessing the quality of the included studies, a practice trial of scoring was performed by two authors (MJA and CWG) on two articles (not included in this analysis) to ensure understanding of the quality criteria. The two authors independently rated the quality of each article. A second meeting was needed to clarify the grading of articles for four items within the risk of bias criteria (item 6, 7, 8, and 11). These items are not always fully addressed in the methods and results sections for immediate effects studies, because they are more relevant to longitudinal trials. After completion of independent grading, the authors met to finalize the scores for each article. Disagreements regarding article quality were resolved by consensus. If consensus could not be reached, a third author (MEH) was recruited to resolve discrepancy.

Data analysis
-------------

We used Microsoft Excel 2007 and PASW Statistics, version 20 (SPSS Inc, Chicago, IL) to examine and compile individual study descriptive statistics, congruence between changes in pain sensitivity and clinical pain, and reviewer agreement. For meta-analytical procedures, we used Comprehensive Meta-Analysis, Version 2 (Biostat Inc, Englewood, NJ). Alpha was set at the 0.05 level for statistical significance.

We estimated congruence between changes in pain sensitivity and clinical pain using Kappa agreement and 95% confidence interval (CI). We examined the agreement for article methodologic quality using intraclass correlation coefficient and 95% CI. We used guidelines for interpreting Kappa and intraclass correlation coefficient values proposed by Landis and Koch et al[@b31-jpr-6-007] and Portney and Watkins et al,[@b32-jpr-6-007] where values \< 0 indicate no agreement and 0--0.20 as slight, 0.21--0.40 as fair, 0.41--0.60 as moderate, 0.61--0.80 as substantial, and 0.81--1 as almost perfect agreement.[@b31-jpr-6-007],[@b32-jpr-6-007]

Conducting the meta-analysis was dependent on having an adequate number of trials (eg, more than two) that used similar study methodology. We based this decision primarily on the pain sensitivity measure where studies needed to use the same experimental sensory modality (ie, pressure, heat, electricity) and measure a similar psychophysical response (ie, threshold, tolerance). In some studies, multiple immediate measurements of the same pain sensitivity outcome were obtained from the same anatomical region (ie, low back or upper extremity). In these cases, we generated a single composite effect for that region using the methods for combining multiple outcomes described by Borenstein.[@b33-jpr-6-007] We computed individual effect size estimates (Hedges g) for each group within each study using information provided in the articles.

We generated separate random-effects models for each pain sensitivity outcome. The primary comparison was a mean difference (eg, pre-to-post change) on the pain sensitivity measure between the group receiving MBT and the comparison group or groups. In cases where multiple treatment arms were included in a single study, we used the following approach. We collapsed comparison group data if groups were in the same category. We categorized comparison groups as active, sham, or control (no treatment) using the definitions in eligibility criteria. We examined dissimilar comparison groups separately. When multiple MBT treatment groups were included in a study, we examined these groups separately within the meta-analysis. We computed an overall pooled Hedges g effect size estimate, with 95% CI as the measure of effect for MBT. Effect size estimates were considered small (0.20), medium (0.50), or large (0.80).[@b34-jpr-6-007] Last, we evaluated homogeneity of the estimated effects using a measure of inconsistency (I^2^), where large values of I^2^ suggest heterogeneity.

We performed two planned subgroup analyses. We planned a stratified analysis by population (healthy versus clinical) and comparison treatment (active versus sham versus control). We categorized population groups as "healthy" (asymptomatic participants) or "clinical" (symptomatic participants) based on the study description. Studies that induced delayed onset muscle soreness or included subjects based on the presence of trigger points were not considered strictly clinical or healthy, and thus were withheld based on the difficulty of placing them into a category. We also stratified our analysis by comparison group where the effects of MBT were examined separately for active, sham, and control group comparisons.

Results
=======

Study selection
---------------

We identified a total of 1084 articles from the systematic search of MEDLINE (n = 582) and CINAHL (n = 502), and nine articles from a review of reference lists. After removing duplicates, we screened and assessed 995 titles. Of these, we excluded 939 articles after title or abstract screening. We selected the full texts of 39 articles to be screened by two independent reviewers. Twenty-three studies were excluded based on study design,[@b35-jpr-6-007] inability to compare the effects of a single session of MBT,[@b36-jpr-6-007]--[@b52-jpr-6-007] intervention was not considered MBT,[@b53-jpr-6-007]--[@b57-jpr-6-007] or no pain sensitivity measure.[@b58-jpr-6-007]--[@b67-jpr-6-007] As a result, 23 articles representing 24 studies were identified as meeting the criterion for inclusion in this review. [Figure 1](#f1-jpr-6-007){ref-type="fig"} depicts a flow diagram of the study selection process with reasons for exclusion at each stage. Hou et al reported on two separate study designs that included separate samples, and both studies were included. Thirteen of the studies compared two groups.[@b68-jpr-6-007]--[@b80-jpr-6-007] Nine of the studies compared three groups.[@b28-jpr-6-007],[@b81-jpr-6-007]--[@b87-jpr-6-007] Two studies compared six groups.[@b88-jpr-6-007]

Characteristics of studies
--------------------------

[Table 2](#t2-jpr-6-007){ref-type="table"} provides characteristics of each study, including the sample population, description of muscle-biased interventions and comparison groups, method of assessing pain sensitivity, and outcomes.

Sample population
-----------------

A total of 1318 participants (62% female) were enrolled in the included studies. Five studies (n = 300, 57% female) included healthy participants.[@b68-jpr-6-007],[@b76-jpr-6-007],[@b79-jpr-6-007],[@b81-jpr-6-007],[@b84-jpr-6-007] Two studies (n = 106, 44% female) included healthy participants and then exposed them to eccentric exercise in a controlled laboratory setting to induce delayed onset muscle soreness.[@b29-jpr-6-007],[@b69-jpr-6-007] Sixteen studies (n = 912, 66% female) included a clinical population. The clinical conditions included low back pain (five studies),[@b71-jpr-6-007]--[@b73-jpr-6-007],[@b82-jpr-6-007],[@b85-jpr-6-007] neck pain (five studies),[@b28-jpr-6-007],[@b74-jpr-6-007],[@b77-jpr-6-007],[@b86-jpr-6-007],[@b88-jpr-6-007] tension-type headache (one study),[@b80-jpr-6-007] individuals with myofascial trigger points (two studies),[@b83-jpr-6-007],[@b87-jpr-6-007] breast cancer survivors (one study),[@b75-jpr-6-007] shoulder pain (one study),[@b70-jpr-6-007] and preseason sport-related muscle soreness (one study).[@b78-jpr-6-007]

MBT characteristics
-------------------

A variety of MBT was described across the 23 articles. A total of 36 groups (n = 823) received an MBT treatment. Sixteen studies included a single MBT group,[@b68-jpr-6-007]--[@b71-jpr-6-007],[@b73-jpr-6-007]--[@b76-jpr-6-007],[@b78-jpr-6-007],[@b79-jpr-6-007],[@b81-jpr-6-007],[@b82-jpr-6-007],[@b84-jpr-6-007],[@b85-jpr-6-007],[@b87-jpr-6-007] seven studies included two MBT groups,[@b28-jpr-6-007],[@b29-jpr-6-007],[@b72-jpr-6-007],[@b74-jpr-6-007],[@b77-jpr-6-007],[@b83-jpr-6-007],[@b86-jpr-6-007] and one study employed six MBT groups.[@b88-jpr-6-007] One study (two of the 36 MBT groups) did not provide adequate descriptive statistics to discern group changes in pain sensitivity over time.[@b28-jpr-6-007] Twenty-five (74%, n = 609) of the 34 MBT groups reported a favorable change, (ie, reduced pain sensitivity). No change in pain sensitivity was reported for nine of the 34 groups (26%, n = 184).

Intensity of MBT
----------------

Twenty-three of the 24 studies provided adequate information to discern whether the MBT induced pain or not. One study (two MBT groups, n = 30) did not.[@b28-jpr-6-007] Twenty-one (62%, n = 491) of the 34 MBT treatments provoked pain during the treatment session. Nineteen (90%, n = 475) of the 21 pain-induced groups had a positive effect on pain sensitivity, and two (10%, n = 16) had no effect. Thirteen (38%, n = 302) of the 34 MBT treatments did not provoke pain during the treatment. Five of the 13 nonpain groups (38%, n = 134) had a positive effect on pain sensitivity and seven (54%, n = 168) had no effect. A significantly greater proportion of the MBT treatments that induced pain during the session had a positive effect on pain sensitivity than MBT treatments that did not induce pain during the session, (χ^2^ = 9.17, *P* \< 0.01).

Duration of MBT
---------------

All of the studies provided adequate information to discern the approximate duration of the MBT session. Twenty-six of the MBT treatments (72%, n = 479) lasted less than 8 minutes (short duration). The duration of treatment in the remaining 10 groups (28%, n = 344) lasted 16 minutes or more (long duration). None of the included studies used an MBT technique lasting between 8 and 16 minutes (medium duration). One study, with two groups (n = 30) receiving short-duration interventions, did not report mean changes in pain sensitivity over time.[@b28-jpr-6-007] Eighteen (75%, n = 307) of the 24 short-duration sessions had a positive effect on pain sensitivity, and six (25%, n = 142) had no effect. Seven (70%, n = 302) of the 10 long-duration sessions had a positive effect on pain sensitivity and three (30%, n = 48) had no effect. There was no difference in the proportion of studies reporting a positive effect on pain sensitivity based on session duration (ie, short versus long, χ^2^ = 0.091, *P* \> 0.05).

Comparison interventions
------------------------

A total of 29 (n = 575) comparison groups were described across the 23 articles. Eight of the groups (n = 166) were no treatment control groups. Seven of those rested for a comparable amount of time as the active MBT intervention, and one group received 40 minutes of back pain education, including home exercise instruction. Six (75%, n = 118) of eight groups showed no change (ie, no effect) in pain sensitivity. One group (12.5%, n = 20) showed a negative effect on pain sensitivity (ie, increase in pain sensitivity), and one group (12.5%, n = 28) showed a favorable effect on pain sensitivity (ie, decrease in pain sensitivity).

Eleven of the groups (n = 219) received an inert/sham intervention. The inert/sham interventions included inactive ultrasound (five groups), a touch control of similar duration as the active intervention (four groups) and inactive endermology (light skin suction, two groups). One study (n = 15) did not provide adequate descriptive statistics to discern group changes in pain sensitivity over time.[@b28-jpr-6-007] Three (30%, n = 73) of ten groups showed a positive effect on pain sensitivity and seven (70%, n = 131) groups had no effect.

Ten of the groups (n = 200) received an active intervention. Active interventions included single or combinations of physical modalities (seven groups) and joint-biased interventions (three groups). Seven (70%, n = 121) of the ten groups showed a positive effect on pain sensitivity and three (30%, n = 79) groups had no effect.

Pain sensitivity measures
-------------------------

There were different characteristics of pain sensitivity outcomes reported across the studies. Only two types of sensory modalities were reported, ie, mechanical pressure (24 studies) and electricity (one study).[@b85-jpr-6-007] The psychophysical responses were primarily static measures of pain processing, pain threshold (22 studies), pain tolerance (two studies),[@b88-jpr-6-007] and a pain intensity rating of a fixed suprapain threshold stimulus (two studies).[@b81-jpr-6-007],[@b86-jpr-6-007] Eighteen studies measured changes in pain sensitivity within the same anatomical region where the intervention was performed. Three studies obtained measures in an anatomical region remote from the region receiving treatment.[@b68-jpr-6-007],[@b80-jpr-6-007],[@b87-jpr-6-007] Two studies obtained measurements in both the region being treated and in a remote location.[@b69-jpr-6-007],[@b79-jpr-6-007] Eleven studies reported on both changes in clinical pain and pain sensitivity measures.[@b70-jpr-6-007]--[@b74-jpr-6-007],[@b77-jpr-6-007],[@b78-jpr-6-007],[@b80-jpr-6-007],[@b82-jpr-6-007],[@b85-jpr-6-007],[@b88-jpr-6-007] In those studies, irrespective of random group assignment, there was a moderately strong congruence between changes in pain sensitivity and changes in clinical pain, kappa = 0.446 (*P* = 0.01), 95% CI (0.269--0.623).[@b31-jpr-6-007]

Methodologic quality
--------------------

The assessment of potential risk of bias for the 23 articles is shown in [Table 3](#t3-jpr-6-007){ref-type="table"}. Quality score agreement between the two primary raters (MJA and CWG) was good with an intraclass correlation coefficient of 0.67 (95% CI 0.21--0.86). The involvement of a third rater (MEH) was needed to resolve disagreements over criteria item 2, concealment of treatment allocation, for three studies.[@b28-jpr-6-007],[@b77-jpr-6-007],[@b81-jpr-6-007] Of the 23 studies included in the review, none were considered at low risk of bias (ie, high quality), 18 of the studies were considered at unclear risk of bias (plausible bias for one or more key domains), and five studies at high risk of potential bias (ie, low quality). Across studies, there was consistent plausible risk of performance and detection bias contributing to the overall quality being assessed as "unclear risk of bias", meaning that most information was gathered from studies at low or unclear risk of bias. Insufficient blinding of patients and practitioners, and the inability to account for other potential threats to validity were the major methodologic limits throughout the 23 studies. The five studies rated as at high risk of bias additionally failed to blind the assessor and/or report on baseline characteristics of the groups being compared (increasing the potential detection and selection bias, respectively). In general, due to the nature of the studies (ie, immediate pre-post design) there was low risk of attrition bias. It is difficult to assess for reporting bias because the majority of studies used pain sensitivity tests as secondary outcome measures and not primary clinical measures.

Meta-analysis results
---------------------

Seventeen of the 24 studies were eligible for meta-analysis.[@b29-jpr-6-007],[@b70-jpr-6-007]--[@b76-jpr-6-007],[@b78-jpr-6-007]--[@b80-jpr-6-007],[@b82-jpr-6-007]--[@b84-jpr-6-007],[@b87-jpr-6-007],[@b88-jpr-6-007] All 17 studies examined an immediate effect of MBT on pressure pain thresholds. The overall effect estimate generated from the random effects model (I^2^ = 44.0%, *P* \< 0.05) suggested a small, favorable effect of MBT on increasing pressure pain threshold response as compared with all other interventions (Hedges g = 0.254 \[95% CI 0.105--0.403\], *P* \< 0.05, [Figure 2](#f2-jpr-6-007){ref-type="fig"}).

The same 17 studies were able to be stratified by comparison group and the results are depicted in [Figure 2](#f2-jpr-6-007){ref-type="fig"}. Five studies included comparisons of MBT with active treatment (I^2^ = 45.2%, *P* = 0.12), ten with sham treatment (I^2^ = 0.0%, *P* = 0.55), and eight with no-treatment controls (I^2^ = 60.4%, *P* \< 0.05). A small, favorable effect on increasing pressure pain thresholds was observed when MBT was compared with sham treatments (Hedges g = 0.268 \[95% CI 0.078--0.457\], *P* \< 0.05) and a small-to-moderate, favorable effect when compared with no-treatment controls (Hedges g = 0.471 \[95% CI 0.113--0.830\], *P* \< 0.05). No favorable effect was observed when MBT was compared with other active interventions (Hedges g = 0.036 \[95% CI −0.289--0.362\], *P* = 0.83). Twelve of the 17 studies were stratified based on sample population and the results are depicted in [Figure 3](#f3-jpr-6-007){ref-type="fig"}. Five studies were removed because they included individuals with induced pain (eg, delayed-onset muscle soreness) or nonclinical trigger points. Ten studies examined the effect of MBT on pressure pain threshold responses in clinical participants (I^2^ = 66.0%, *P* \< 0.05), while five studies examined these effects in healthy participants (I^2^ = 0.0%, *P* = 0.41). A small-to-moderate, favorable effect on increasing pressure pain thresholds following MBT was seen in studies with clinical participants (Hedges g = 0.454 \[95% CI 0.112--0.796\], *P* \< 0.05). A small, favorable effect was seen in studies with healthy participants (Hedges g = 0.205 \[95% CI −0.036--0.445\], *P* = 0.10), but was not statistically significant.

Discussion
==========

We conducted a comprehensive systematic review of the literature to address the three key questions of whether MBT affects pain sensitivity, whether MBT intensity and/or duration influences pain sensitivity, and whether short-term changes in pain sensitivity are associated with changes in clinical pain over similar time points. Our results suggest that a single session of MBT has a favorable effect on measures of pain sensitivity. Further, the degree of pressure intensity used during treatment seems to influence the effect because a significantly greater proportion of studies reported a favorable effect on pain sensitivity when the intervention induced tolerable amounts of pain during the treatment compared with interventions that did not induce tolerable amounts of pain. Finally, the changes in pain sensitivity reported in the studies were related to changes in clinical pain intensity, thus highlighting the clinical relevance of pain sensitivity.

Prior reviews of the clinical effectiveness of MBT to relieve pain have been inconclusive, and the administration of inadequate treatments may account for the lack of effect in some studies.[@b7-jpr-6-007],[@b17-jpr-6-007] One of the issues that may be related to the lack of effect is that optimal treatment parameters for MBT in treatment of musculoskeletal pain conditions are not known. The review by Lewis et al reported variation in duration and dosage parameters of massage interventions and suggested that the dosage may be inadequate.[@b7-jpr-6-007] The review herein also found variation across the duration of a single MBT session; however, interventions that were excluded in the previous review were included herein, which could account for additional variability. This review expands upon prior work and reports on variation in the ability of some interventions to reduce pain sensitivity, and suggests the perceived intensity of pressure applied during MBT may be an important parameter. Our results confirm that heterogeneity exists across MBT interventions, and there is a need to establish optimal MBT parameters. Further, our results suggest that pain sensitivity may be a viable intermediate physiologic endpoint in determining adequate treatment protocols.

The findings of this review have implications for future mechanistic MBT research. The gate control theory of pain is often implicated as the neurophysiologic mechanism underlying symptomatic pain relief.[@b12-jpr-6-007] Through activation of non-noxious afferents, ongoing nociceptive transmission is inhibited.[@b7-jpr-6-007] Our finding that inducing a tolerable amount of pain during a treatment session may preferentially affect pain sensitivity suggests that additional mechanisms may be involved, such as conditioned pain modulation, also known as diffuse noxious inhibitory control. This lends further support for a recent model of the mechanisms of all manual therapies, including muscle, joint, and nerve biased techniques, that suggests changes in pain are related to an interaction of neurophysiologic responses in the peripheral and central nervous system that may involve several analgesic pathways.[@b26-jpr-6-007]

This review has clinical implications for future studies. First, these findings support that short-term reductions in pain sensitivity are a potential mechanism underlying short-term clinical benefit. Increased pain sensitivity is associated with a number of clinical pain conditions and is offered as a mechanistic explanation of pain persistence and a therapeutic target.[@b89-jpr-6-007] Thus, MBT is a viable treatment option to reduce pain sensitivity. Future investigations will need to explore the link between short-term changes and long-term clinical improvement. Second, clinical pain is multidimensional (ie, affective-motivational, sensory-discriminative) and evidence suggests different dimensions may reflect diverse underlying mechanisms.[@b90-jpr-6-007]--[@b92-jpr-6-007] The evidence also suggests that treatments may preferentially improve some dimensions over others.[@b21-jpr-6-007],[@b93-jpr-6-007],[@b94-jpr-6-007] Reductions in measures of pain sensitivity are associated with improvements in movement-related pain to a greater extent than improvements in spontaneous pain.[@b21-jpr-6-007] The primary outcome in many MBT clinical trials is commonly single-dimension measures (eg, visual analog scale scores, numerical rating scale scores, and verbal rating scale scores) of pain intensity, potentially making assessment of treatment effects for MBT challenging. Future clinical studies of the effectiveness of MBT may consider assessing movement-related and spontaneous pain separately, in addition to recommended single-dimension measures.

Limitations
===========

There are several limitations to this review. We did not account for the type of practitioner applying the intervention, the years of experience of the practitioner delivering the intervention, the duration of pain in the clinical populations (ie, acute versus chronic), differences across the MBT treatments in their intended aim (short-term pain relief versus long-term improvement in condition), and changes in other physiologic measures. Thus, caution is recommended when applying the results of this review to clinical practice and for developing optimal therapeutic MBT protocols. Only one of several proposed mechanisms underlying clinical improvement was included, ie, pain sensitivity. Other systematic reviews have reported that MBT decreases psychologic measures of anxiety and tension, promotes feelings of well-being and relaxation, and induces changes in physiologic indicators of relaxation, such as heart rate and blood pressure.[@b95-jpr-6-007],[@b96-jpr-6-007] Interactions between the patient's perceived intensity of MBT and other intermediate physiologic endpoints are not known. Additional consideration should be given to the patient's perceptions regarding the effectiveness of MBT (ie, beliefs) and the patient's preference for using amounts of perceived pressure that may induce levels of pain. Future research into developing optimal MBT protocols should consider several potential physiologic intermediate endpoints simultaneously, treatment expectations, and patient preference.

While relatively few studies had a high risk of bias for any one domain, all of the studies presented herein had unclear performance bias, which raises some doubt about the results being only attributable to exposure to the intervention and not other factors. Adequate blinding of participants, practitioners, and outcome assessors is difficult for all studies, and the increased difficulty has been well documented for many complementary and alternative medicine approaches, especially manipulative and body-based therapies.[@b97-jpr-6-007] Nonetheless, performance bias is likely to be introduced when blinding is not adequate. Further, the inclusion of a "sham" treatment arm in a study does not alone adequately control for potential systematic differences between groups that could account for the results. Post-randomization checks should be included and reported for such trials. The simple questions of "what do you expect from this treatment?" and "which group do you believe to belong to?" have been offered as additional ways to help maintain internal validity.[@b98-jpr-6-007] An additional limitation is the lack of consistent reporting of pain sensitivity outcome measures and descriptions of the MBT intervention. When baseline and post-treatment means and standard deviations are not reported by authors, it is difficult to conduct meta-analyses. The duration of MBT interventions are generally well described. However, the intensity of treatment and whether subjects experienced pain during the treatment is not easily discernible. For example, using only descriptive terms such as deep and/or light pressure requires assumptions to be made regarding how the subjects perceived the pressure. An alternative approach would be to standardize the amount of pressure and pain to a general amount that is experienced by the subjects during treatment.

Without a post-randomization or post-treatment measurement of whether or not the patients believed they received the active or inactive treatment, or if they felt they were receiving a treatment that might benefit them (ie, expectation), it is difficult to assess if differences existed between groups. Even for studies that attempted to blind the patients where "sham" techniques were applied, no measure of effectiveness of the blinding process was reported; thus a true "sham" or placebo treatment cannot be assumed. Previous research has shown that patient expectations affect pain sensitivity, which was the primary outcome measure of this review. Therefore patient expectations represent a relevant risk of bias. Further differences in expectation have been shown to be better predictors of short-term and long-term clinical improvement than group assignment to either genuine or "sham" acupuncture.[@b99-jpr-6-007] Moreover, manipulations of expectation have shown the ability to enhance and diminish the analgesic effects of a potent synthetic μ-opioid agonist and forms of manual therapy.[@b100-jpr-6-007],[@b101-jpr-6-007] Unfortunately, assessing for potential contributions of group assignment based on positive or negative expectations is not routinely done in this area of research and contributes to plausible biases that raise concern over the internal validity of results.

Conclusion
==========

MBT demonstrates the ability to modulate pain sensitivity in a fairly consistent and favorable manner. It appears the intensity at which the MBT is delivered during the session but not the duration, which may preferentially affect the magnitude of reduction, and further research is needed to validate these findings. The evidence herein supports the use of pain sensitivity measures in future research as an intermediate physiologic marker to help elucidate optimal therapeutic parameters.
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![Flow chart of study identification, selection, and inclusion.\
**Abbreviation:** CINAHL, Cumulative Index to Nursing and Allied Health Literature.](jpr-6-007f1){#f1-jpr-6-007}

![Forest plot depicting overall effect of MBT across all studies and subgroup effect of MBT based on type of comparison group.\
**Notes:** Open diamond depicts overall effect size across all studies. Colored diamonds depict subgroup effect size based on type of comparison group. For example, top colored diamond is effect size for MBT studies with active comparison groups. The width of diamond corresponds to its 95% CI (listed in figure). Individual study effect sizes (and 95% CI) are depicted with boxes (whiskers). Box and whisker size and thickness for each individual study illustrate the weighted contribution of that study to the overall effect size (eg, larger boxes/thicker lines contribute more to overall effect size). ^a^Active comparison; ^b^sham comparison; ^c^control comparison; ^d^MBT arm received superficial pressure; ^e^MBT arm received deep pressure; ^f^MBT arm received ischemic compression; ^g^MBT arm received trigger point therapy.\
**Abbreviations:** CI, confidence interval; MBT, muscle-biased therapy.](jpr-6-007f2){#f2-jpr-6-007}

![Forest plot depicting subgroup effect of MBT based on type of sample population.\
**Notes:** Open diamond depicts overall effect size across all studies included in this subgroup analysis. Colored diamonds depict subgroup effect size based on type of comparison group. For example, top colored diamond is effect size for MBT studies with clinical samples. The width of diamond corresponds to its 95% CI (listed in figure). Individual study effect sizes (and 95% CI) are depicted with boxes (whiskers). Box and whisker size and thickness for each individual study illustrate the weighted contribution of that study to the overall effect size (eg, larger boxes/thicker lines contribute more to overall effect size). ^a^Sham comparison; ^b^control comparison; ^c^active comparison.\
**Abbreviations:** CI, confidence interval; MBT, muscle-biased therapy.](jpr-6-007f3){#f3-jpr-6-007}

###### 

Database search strategy performed August 1, 2012

  Number                                                                                                                                             Search terms                                                         MEDLINE results   CINAHL results
  -------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------- ----------------- ----------------
  **Database search strategy**                                                                                                                                                                                                              
  1                                                                                                                                                  Musculoskeletal manipulations \[MESH; major topic\]                  7032              7
  2                                                                                                                                                  "Manual therapy"                                                     1740              2586
  3                                                                                                                                                  "Massage"                                                            10,457            7432
  4                                                                                                                                                  "Alternative therapies"                                              2833              18,775
  5                                                                                                                                                  "Myofascial release"                                                 76                227
  6                                                                                                                                                  "Myofascial therapy"                                                 20                24
  7                                                                                                                                                  "Trigger point therapy"                                              45                143
  8                                                                                                                                                  1 or 2 or 3 or 4 or 5 or 6 or 7                                      18,803            27,581
  9                                                                                                                                                  "Pain" \[MESH; major topic\]                                         174,141           52,073
  10                                                                                                                                                 "Pain measurement" \[MESH; major topic\]                             7773              3444
  11                                                                                                                                                 "Quantitative sensory testing"                                       728               189
  12                                                                                                                                                 "Thermal pain"                                                       596               91
  13                                                                                                                                                 "Electrical pain"                                                    144               34
  14                                                                                                                                                 "Pressure pain"                                                      1033              420
  15                                                                                                                                                 "Mechanical pain"                                                    417               81
  16                                                                                                                                                 "Pain threshold"                                                     10,014            1553
  17                                                                                                                                                 "Muscle pain"                                                        2153              1293
  18                                                                                                                                                 "Experimental pain"                                                  1059              203
  19                                                                                                                                                 "Trigger point"                                                      546               766
  20                                                                                                                                                 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19   183,382           53,510
  15                                                                                                                                                 8 AND 20                                                             2087              2635
  **Search limits**                                                                                                                                                                                                                         
  MEDLINE limits: "abstracts", "humans", "clinical trial", "randomized controlled trial", and "English"                                              582                                                                                    
  CINAHL limits: "abstract available", "English language", "peer reviewed", "research article", "human", and "all adult" after removing duplicates                                                                        502               

**Abbreviation:** CINAHL, Cumulative Index to Nursing and Allied Health Literature.

###### 

Characteristics of included studies

  Author (study design)                                                   Population (n)                                    Induced pain   Duration (minutes)   Measure                                                                                                                                    Raw mean difference (SD)                       Pain sensitivity   Clinical pain
  ----------------------------------------------------------------------- ------------------------------------------------- -------------- -------------------- ------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------- ------------------ ---------------
  Aguilera et al[@b81-jpr-6-007] (RCT)                                    Healthy (n = 68)                                                                                                                                                                                                                                                                                   
   MBT, ischemic compression                                              24                                                \+             1.5                  STR[\*](#tfn3-jpr-6-007){ref-type="table-fn"}                                                                                              8.23 (14.78)                                   \+                 NA
   Com AT, ultrasound                                                     22                                                               4                                                                                                                                                               7.50 (7.86)                                    \+                 NA
   Com IT, sham ultrasound                                                22                                                               5                                                                                                                                                               1.50 (7.62)                                    −                  NA
  Aparicio et al (RCT)[@b68-jpr-6-007]                                    Healthy (n = 70)                                                                                                                                                                                                                                                                                   
   MBT, manual pressure                                                   36                                                −              2                    PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"},[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                     0.36 (1.43)                                    −                  NA
   Com AT, distraction of facial joints                                   34                                                               2                                                                                                                                                               0.05 (1.00)                                    −                  NA
  Arroyo-Morales et al[@b69-jpr-6-007] (RCT)                              Healthy subjects/lower extremity DOMS (n = 62)                                                                                                                                                                                                                                                     
   MBT, massage                                                           32                                                −              40                   PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"},[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                     0.35 (0.66)                                    \+                 NA
   Com IT, sham ultrasound                                                30                                                               40                                                                                                                                                              0.20 (0.67)                                    \+                 NA
  Blikstad and Gemmell[@b28-jpr-6-007] (RCT)                              Neck pain with MTrPs (n = 45)                                                                                                                                                                                                                                                                      
   MBT, myofascial therapy                                                15                                                −              2                    PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                                                               UTC                                            UTC                UTC
   MBT, activator (mechanical device)                                     15                                                −              2                                                                                                                                                               UTC                                            UTC                UTC
   Com IT, sham ultrasound                                                15                                                               2                                                                                                                                                               UTC                                            UTC                UTC
  Buttagat et al[@b70-jpr-6-007] (RCT)                                    Scapulocostal syndrome (n = 20)                                                                                                                                                                                                                                                                    
   MBT, Thai massage                                                      10                                                \+             30                   PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                                                               0.90 (0.85)                                    \+                 \+
   Com AT, hot pack and ultrasound                                        10                                                               30                                                                                                                                                              0.10 (0.85)                                    −                  −
  Buttagat et al[@b71-jpr-6-007] (RCT)                                    Low back pain with MTrPs (n = 36)                                                                                                                                                                                                                                                                  
   MBT, Thai massage                                                      18                                                \+             30                   PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                                                               1.40 (1.03)                                    \+                 \+
   Com NT, rest                                                           18                                                               30                                                                                                                                                              0.00 (1.00)                                    −                  −
  Chatchawan et al[@b72-jpr-6-007] (RCT)                                  Low back pain (n = 180)                                                                                                                                                                                                                                                                            
   MBT -- Swedish massage                                                 90                                                \+             30                   PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                                                               0.20 (1.10)                                    \+                 \+
   MBT -- Thai massage                                                    90                                                \+             30                                                                                                                                                              0.30 (1.10))                                   \+                 \+
  Farasyn et al[@b82-jpr-6-007] (RCT)                                     Low back pain (n = 60)                                                                                                                                                                                                                                                                             
   MBT, roptrotherapy (instrument)                                        20                                                \+             30                   PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"},[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                     1.03 (1.03)                                    \+                 \+
   Com IT, sham endermology                                               20                                                               30                                                                                                                                                              0.00 (1.38)                                    −                  −
   Com NT, rest                                                           20                                                               30                                                                                                                                                              −0.10 (0.49)                                   neg                −
  Farasyn and Meeusen[@b73-jpr-6-007] (RCT)                               Low back pain (n = 58)                                                                                                                                                                                                                                                                             
   MBT, roptrotherapy (instrument)                                        42                                                \+             30                   PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"},[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                     1.03 (1.34)                                    \+                 \+
   Com IT, sham endermology                                               20                                                               30                                                                                                                                                              0.00 (1.27)                                    −                  NR
  Fernández-de-las-Peñas et al[@b74-jpr-6-007] (RCT)                      Neck pain (n = 40)                                                                                                                                                                                                                                                                                 
   MBT, ischemic compression                                              20                                                \+             1.5                  PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                                                               0.40 (0.55)                                    \+                 \+
   MBT, transverse friction massage                                       20                                                \+             3                                                                                                                                                               0.35 (0.40)                                    \+                 \+
  Fernandez-Lao et al[@b75-jpr-6-007] (RCOT)                              Breast cancer survivors (n = 20)                                                                                                                                                                                                                                                                   
   MBT, myofascial release                                                20                                                −              40                   PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"},[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                     6.20 (60.86)                                   −                  NA
   Com NT, attention control                                              20                                                               40                                                                                                                                                              3.30 (54.81)                                   −                  NA
  Frey Law et al[@b29-jpr-6-007] (RCT)                                    Healthy subjects/upper extremity DOMS (n = 39)                                                                                                                                                                                                                                                     
   MBT, deep touch treatment                                              13                                                −              6                    PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                                                               13.30 (70.3)                                   \+                 NA
   MBT, light touch treatment                                             15                                                −              6                                                                                                                                                               11.10 (61.35)                                  \+                 NA
   Com NT, rest                                                           11                                                               6                                                                                                                                                               −7.3 (65.9)                                    −                  NA
  Fryer and Hodgson[@b76-jpr-6-007] (RCT)                                 Healthy (n = 37)                                                                                                                                                                                                                                                                                   
   MBT, myofascial release                                                20                                                \+             1                    PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                                                               2.05 (1.70)                                    \+                 NA
   Com IT, touch control                                                  17                                                               1                                                                                                                                                               0.08 (1.70)                                    −                  NA
  Gemmell and Allen 2008a[@b77-jpr-6-007] (RCT)                           Neck pain with MTrPs (n = 52)                                                                                                                                                                                                                                                                      
   MBT, ischemic compression                                              25                                                \+             1                    PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                                                               1.1 (1.9)                                      \+                 \+
   MBT, activator (mechanical device)                                     27                                                −              1                                                                                                                                                               1.4 (1.2)                                      \+                 \+
  Gemmell et al 2000b[@b83-jpr-6-007] (RCT)                               Subjects with MTrPs in trapezius mm (n = 45)                                                                                                                                                                                                                                                       
   MBT, ischemic compression                                              15                                                \+             1                    PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                                                               1.06 (1.43)                                    \+                 NA
   MBT, trigger point therapy                                             15                                                −              1.5                                                                                                                                                             0.97 (1.48)                                    \+                 NA
   Com IT, sham ultrasound                                                15                                                               2                                                                                                                                                               0.77 (1.23)                                    \+                 NA
  Hamilton et al[@b84-jpr-6-007] (RCT)                                    Healthy (n = 90)                                                                                                                                                                                                                                                                                   
   MBT, muscle energy technique                                           30                                                −              1 min                PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                                                               42.04 (162.62)                                 −                  NA
   Com AT, joint-biased therapy                                           35                                                               1 min                                                                                                                                                           39.37 (132.82)                                 −                  NA
   Com IT, touch control                                                  25                                                               1 min                                                                                                                                                           15.88 (181.96)                                 −                  NA
  Hou et al[@b88-jpr-6-007] (RCT)                                         Neck pain (n = 48)                                                                                                                                                                                                                                                                                 
   MBT, pain threshold pressure                                           8                                                 \+             0.5                  PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}; Ptol[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                0.00 (0.99); 0.06 (1.40)                       −; −               \+
   MBT, pain threshold pressure                                           8                                                 \+             1                                                                                                                                                               0.07 (0.64); 0.07 (0.86)                       −; −               \+
   MBT, pain threshold pressure                                           8                                                 \+             1.5                                                                                                                                                             0.79 (1.02); 0.85 (1.18)                       +; +               \+
   MBT, pain tolerance pressure                                           8                                                 \+             0.5                                                                                                                                                             0.67 (0.87); 0.10 (0.98)                       +; +               \+
   MBT, pain tolerance pressure                                           8                                                 \+             1                                                                                                                                                               0.72 (0.76); 0.71 (0.99)                       +; +               \+
   MBT, pain tolerance pressure                                           8                                                 \+             1.5                                                                                                                                                             1.02 (0.71); 0.98 (1.33)                       +; +               \+
  Hou et al[@b88-jpr-6-007] (RCT)                                         Neck pain (n = 71)                                                                                                                                                                                                                                                                                 
   MBT, control + ischemic compression                                    13                                                \+             13.5                 PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}; Ptol[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                0.42 (0.74)                                    +; +               \+
   Com AT, multiple modalities[a](#tfn5-jpr-6-007){ref-type="table-fn"}   58                                                               25                                                                                                                                                              0.63 (0.38)                                    +; +               \+
  Lewis et al[@b85-jpr-6-007] (RCT)                                       Low back pain (n = 28)                                                                                                                                                                                                                                                                             
   MBT, strain-counterstrain                                              28                                                −              1.5                  PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"}; EDT[a](#tfn5-jpr-6-007){ref-type="table-fn"}; EPT[a](#tfn5-jpr-6-007){ref-type="table-fn"}   93.40 (268.89); 1.80 (28.35); 15.70 (198.43)   +; −; −            −
   Com IT, sham strain-counterstrain                                      28                                                               1.5                                                                                                                                                             48.30 (207.61); 1.30 (30.78); 6.90 (240.28)    +; −; −            −
   Com NT, rest                                                           28                                                               6                                                                                                                                                               30.70 (219.35); 6.80 (24.43); 18.20 (188.58)   +; +; +            −
  Mancinelli et al[@b78-jpr-6-007] 2006 (RCT)                             General muscle soreness (n = 22)                                                                                                                                                                                                                                                                   
   MBT, massage                                                           11                                                −              17                   PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"},[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                     1.40 (6.05)                                    −                  \+
   Com NT, rest                                                           11                                                               17                                                                                                                                                              −0.15 (6.71)                                   −                  −
  Meseguer et al[@b86-jpr-6-007] (RCT)                                    Neck pain (n = 54)                                                                                                                                                                                                                                                                                 
   MBT, classic strain-counterstrain                                      18                                                \+             5                    STR[\*\*](#tfn4-jpr-6-007){ref-type="table-fn"}                                                                                            2.6 (1.4)                                      \+                 NR
   MBT, modified strain-counterstrain                                     18                                                \+             5                                                                                                                                                               2.6 (1.8)                                      \+                 NR
   Com NT, rest                                                           18                                                               5                                                                                                                                                               0.03 (0.3)                                     −                  NR
  Oliveira-Campelo et al[@b87-jpr-6-007] (RCT)                            Subjects with MTrP in masseter muscle (n = 122)                                                                                                                                                                                                                                                    
   MBT, muscle inhibition technique                                       41                                                −              2                    PPT[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                                                               0.0 (0.70)                                     −                  NR
   Com AT, joint-biased therapy                                           41                                                               2                                                                                                                                                               0.20 (0.70)                                    \+                 NR
   Com NT, rest                                                           40                                                               2                                                                                                                                                               −0.10 (0.70)                                   −                  NR
  Saiz-Llamosas et al[@b79-jpr-6-007] (RCT)                               Healthy (n = 35)                                                                                                                                                                                                                                                                                   
   MBT, myofascial induction                                              19                                                −              5                    PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"},[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                     5.95 (98.06)                                   −                  NA
                                                                                                                                                                PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"},[c](#tfn7-jpr-6-007){ref-type="table-fn"}                                                     −6.40 (285.59)                                                    
   Com IT, touch control                                                  16                                                               5                    PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"},[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                     15.80 (76.01)                                  −                  NA
                                                                                                                                                                PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"},[c](#tfn7-jpr-6-007){ref-type="table-fn"}                                                     −15.85 (184.53)                                                   
  Toro-Velasco et al[@b80-jpr-6-007] (RCOT)                               Chronic tension-type headache (n = 11)                                                                                                                                                                                                                                                             
   MBT, massage                                                           11                                                −              40 min               PPT[a](#tfn5-jpr-6-007){ref-type="table-fn"},[b](#tfn6-jpr-6-007){ref-type="table-fn"}                                                     −8.7 (46.96)                                   −                  \+
   Com IT, sham ultrasound                                                11                                                               40 min                                                                                                                                                          0.80 (56.60)                                   −                  −

**Notes:**

STR, suprathreshold rating to 2.5 kg pressure;

STR, suprathreshold rating to 4.5 kg pressure;

Composite measure;

local measure;

remote location;

both remote and local measurements; Induced pain = Did the intervention induce pain during the session? (+) = Yes; (−) = No; Duration, length of MBT session, reported in minutes; Measure, pain sensitivity measure; Diff in means (SE), estimated within-group difference in pre-intervention and post-intervention mean (standard error); Pain sensitivity = within group effect on pain sensitivity. (+) = favorable; (−) = no change; (neg) = unfavorable effect; Clinical pain = within group effect on clinical report of pain. (+) = favorable; (−) = no change.

**Abbreviations:** RCT, randomized controlled trial; RCOT, randomized crossover trial; MTrP, myofascial trigger point; PPT, pressure pain threshold; Ptol, pressure pain tolerance; EDT, electrical detection threshold; EPT, electrical pain threshold; NR, not reported; NA, not applicable; UTC, unable to compute; MBT, muscle-biased therapy; Com IT, comparative group inert treatment; Com NT, comparative group no treatment; Com ATT, comparative group active treatment; DOMs, delayed-onset muscle soreness.

###### 

Methodological quality assessment of included studies

  Article/criteria                                      1    2    3   4   5    6    7    8   9                    10   11   12   Total   Domains               
  ----------------------------------------------------- ---- ---- --- --- ---- ---- ---- --- -------------------- ---- ---- ---- ------- --------- --- --- --- ---
  Aguilera et al[@b81-jpr-6-007]                        \+   −    −   −   −    \+   \+   ?   \+                   \+   \+   \+   7       U         U   U   L   ?
  Aparicio et al[@b68-jpr-6-007]                        \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Arroyo-Morales et al[@b69-jpr-6-007]                  \+   −    −   −   −    \+   −    ?   \+                   \+   \+   \+   6       L         U   U   L   ?
  Blikstad and Gemmell[@b28-jpr-6-007]                  \+   −    −   −   \+   \+   \+   ?   −                    \+   \+   \+   7       L         U   L   L   ?
  Buttagat et al[@b70-jpr-6-007]                        \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Buttagat et al[@b71-jpr-6-007]                        \+   −    −   −   −    \+   \+   ?   \+                   \+   \+   \+   7       L         U   U   L   ?
  Chatchawan et al[@b72-jpr-6-007]                      \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Farasyn et al[@b82-jpr-6-007]                         \+   −    −   −   −    \+   \+   ?   \+                   \+   \+   \+   7       L         U   U   L   ?
  Farasyn and Meeusen[@b73-jpr-6-007]                   \+   −    −   −   −    \+   \+   ?   \+                   \+   \+   \+   7       U         U   U   L   ?
  Fernández-de-las-Peñas et al[@b74-jpr-6-007] (2006)   \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Fernandez-Lao et al[@b75-jpr-6-007] (2012)            \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Frey Law et al[@b29-jpr-6-007]                        \+   −    −   −   \+   \+   −    ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Fryer and Hodgson[@b76-jpr-6-007]                     \+   \+   −   −   −    \+   \+   ?   \+                   \+   \+   \+   7       L         U   L   L   ?
  Gemmell and Allen[@b77-jpr-6-007] (2008a)             \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Gemmell et al[@b83-jpr-6-007] (2008b)                 \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Hamilton et al[@b84-jpr-6-007]                        \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Hou et al[@b88-jpr-6-007] (2002)                      \+   −    −   −   −    \+   \+   ?   \+                   \+   \+   \+   7       L         U   U   L   ?
  Lewis et al[@b85-jpr-6-007]                           \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Mancinelli et al[@b78-jpr-6-007] (2006)               \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Meseguer et al[@b86-jpr-6-007]                        \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Oliveira-Campelo et al[@b87-jpr-6-007]                \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Saiz-Llamosas et al[@b79-jpr-6-007]                   \+   −    −   −   \+   \+   \+   ?   \+                   \+   \+   \+   8       L         U   L   L   ?
  Toro-Velasco et al[@b80-jpr-6-007]                    \+   \+   −   −   \+   \+   \+   ?   \+                   \+   \+   \+   9       L         U   L   L   ?
                                                                                             Across all studies   L    U    L    L       ?                     

**Notes:** (+) met criteria, (−) did not meet criteria, (?) unsure, (L) low risk of bias, (U) unclear risk of bias, (H) high risk of bias. Criteria: 1 -- was the method of randomization adequate?; 2 -- was the treatment allocation concealed?; 3 -- was the patient blinded to the intervention?; 6 -- was the dropout rate described and adequate?; 7 -- were all randomized participants analyzed in the group which they were allocated?; 8 -- are reports of the study free of suggestion of selective outcome reporting?; 9 -- were the groups similar at baseline regarding the most important prognostic indicators?; 10 -- were con-interventions avoided or similar?; 11 -- was the compliance acceptable in all groups?; 12 -- was the timing of the outcome assessment similar in all groups?. A, selection bias; B, performance bias; C, detection bias; D, attrition bias; E, reporting bias. \*1 point for each item meeting criteria.
